(Q42487904)

English

Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes

scientific article published on July 2000

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

based on heuristic

inferred from title

author name string

Sigrist S

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Bedoucha M

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Boelsterli UA

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

67-75

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Augmented production of tumor necrosis factor-alpha in obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

General Survey of Diabetic Features of Yellow KK Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Laboratory animals exhibiting obesity and diabetes syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Biologically active products of stimulated liver macrophages (Kupffer cells).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Review: regulation of liver regeneration by pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Cytokines and the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Role of hepatocellular regeneration and hepatolobular healing in the final outcome of liver injury. A two-stage model of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Hepatic cell division and tissue repair: a key to survival after liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: a novel dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

An autopsy case of troglitazone-induced fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900299-9

7 January 2021

Identifiers

10.1016/S0006-2952(00)00299-9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42487904&oldid=1984640194"